Erbliche Sehnerverkrankungen

Zusammenfassung

Trotz der Seltenheit haben die erblichen Sehnerverkrankungen den Vorteil, dass sie oftmals durch die Anamnese erkannt werden können und die Diagnosesicherung heute sicher durch eine molekulargenetische Untersuchung geleistet werden kann. Als isolierte erbliche Sehnerverkrankungen sind im augenheilkundlichen Alltag die Leberʼsche hereditäre Optikusneuropathie (LHON) und die autosomal-dominante Optikusatrophie (ADOA) relevant.

Abstract

Hereditary optic nerve disorders are rare. For ophthalmologists, Leberʼs hereditary optic neuropathy (LHON) and autosomal dominant optic atrophy (ADOA) are of particular relevance. LHON and ADOA are diseases of the retinal ganglion cells and are caused by mitchochondrial dysfunction. LHON is based on mutations of the mitochondrial, ADOA of the nuclear DNA. LHON is a disease that usually leads to severe visual impairment (visual acuity < 0.1). Since there is an approved therapy for LHON (Idebenone [Raxone]), the diagnosis has to be confirmed immediately by means of molecular genetic diagnostics. ADOA usually shows less severe visual impairment, begins in childhood, and progresses gradually, often for a long time without any noticeable worsening. Family history (dominant heredity) and blue colour vision disorder are the leading indicators for the diagnosis of ADOA, which should be confirmed by molecular genetic testing. Optic nerve diseases can also occur in the context of hereditary, syndromic disorders. Ophthalmologically relevant are Wolfram syndrome, Friedreichʼs ataxia and Charcot-Marie-Tooth disease. In all hereditary optic nerve disorders, foods containing cyanide and smoking should be avoided. Excessive alcohol consumption is considered to be a trigger of LHON and possibly harmful in other hereditary optic neuropathies. In the management of patients with hereditary optic nerve disorders, aspects of rehabilitation as well as social and psychological care should be considered.

Schlüsselwörter

erbliche Optikusneuropathien - Optikusatrophie - Leberʼsche hereditäre Optikusneuropathie - autosomal-dominante Optikusatrophie - Mitochondriopathie

Key words

hereditary optic nerve disorders - optic atrophy - Leberʼs hereditary optic neuropathy - autosomal dominant optic atrophy - mitochondrial disorders

• Literatur

• 1 Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies – disease mechanisms and therapeutic strategies. Prog Retin Eye Res 2011; 30: 81-114
• 2 Wallace DC, Singh G, Lott MT. et al. Mitochondrial-DNA mutation associated with Leberʼs hereditary optic neuropathy. Science 1988; 242: 1427-1430
• 3 Yu-Wai-Man P, Griffiths PG, Hudson G. et al. Inherited mitochondrial optic neuropathies. J Med Genet 2009; 46: 145-158
• 4 Achilli A, Iommarini L, Olivieri A. et al. Rare primary mitochondrial DNA mutations and probable synergistic variants in Leberʼs hereditary optic neuropathy. PLoS One 2012; 7: e42242
• 5 Yu-Wai-Man PY, Griffiths PG, Brown DT. et al. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet 2003; 72: 333-339
• 6 Rosenberg T, Norby S, Schwartz M. et al. Prevalence and genetics of Leber hereditary optic neuropathy in the Danish population. Invest Ophthalmol Vis Sci 2016; 57: 1370-1375
• 7 Kirkman MA, Korsten A, Leonhardt M. et al. Quality of life in patients with Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci 2009; 50: 3112-3115
• 8 Jurkute N, Yu-Wai-Man P. Leber hereditary optic neuropathy: bridging the translational gap. Curr Opin Ophthalmol 2017; 28: 403-409
• 9 Kirkman MA, Yu-Wai-Man P, Korsten A. et al. Gene-environment interactions in Leber hereditary optic neuropathy. Brain 2009; 132: 2317-2326
• 10 Majander A, Bowman R, Poulton J. et al. Childhood-onset Leber hereditary optic neuropathy. Br J Ophthalmol 2017; 101: 1505-1509 doi:10.1136/bjophthalmol-2016-310072
• 11 Hwang TJ, Karanjia R, Moraes-Filho MN. et al. Natural history of conversion of Leberʼs hereditary optic neuropathy: a prospective case series. Ophthalmology 2017; 124: 843-850
• 12 Barboni P, Carbonelli M, Savini G. et al. Natural history of Leberʼs hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography. Ophthalmology 2010; 117: 623-627
• 13 Balducci N, Savini G, Cascavilla ML. et al. Macular nerve fibre and ganglion cell layer changes in acute Leberʼs hereditary optic neuropathy. Br J Ophthalmol 2016; 100: 1232-1237
• 14 Klopstock T, Yu-Wai-Man P, Dimitriadis K. et al. A randomized placebo controlled trial of idebenone in Leberʼs hereditary optic neuropathy. Brain 2011; 134: 2677-2686
• 15 Yu-Wai-Man P, Griffiths PG, Burke A. et al. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. Ophthalmology 2010; 117: 1531-1546
• 16 Lenaers G, Hamel C, Delettre C. et al. Dominant optic atrophy. Orphanet J Rare Dis 2012; 7: 46
• 17 Zanna C, Ghelli A, Porcelli AM. et al. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 2008; 131(Pt 2): 352-367
• 18 Yu-Wai-Man P, Trenell MI, Hollingsworth KG. et al. OPA1 mutations impair mitochondrial function in both pure and complicated dominant optic atrophy. Brain 2011; 134: e164 doi:10.1093/brain/awq288
• 19 Chan JW. Optic nerve disorders – diagnosis and management. Berlin New York: Springer; 2007
• 20 Eiberg H, Hansen L, Kjer B. et al. Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene. J Med Genet 2006; 43: 435-440